Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In fact, pneumonia occurred less frequently in the brensocatib groups than in patients receiving placebo ( 6.2 BI 1291583 clinical studies 6.2.1 Phase I clinical study Phase I clinical studies of BI 1291583 in healthy volunteers demonstrated favorable safety and efficacy characteristics
doi: 10.1055/s-0042-122344
Active recombinant rat dipeptidyl aminopeptidase I (cathepsin C) produced using the baculovirus expression system
You can read more in our overview of the benefits of peptide therapy
Research has identified several key molecular pathways through which this peptide exerts its cytoprotective and regenerative functions
Exp Cell Res (2020) 394(2):112136
US$ 27.61
US$ 24.71
US$ 23.07
US$ 20.09
US$ 22.63
US$ 24.76
US$ 28.21
US$ 22.53
US$ 27.23
